Form 4: CalciMedica Director Frederic Guerard Granted Stock Options

Director Frederic Guerard received stock options for 10,000 shares of CalciMedica, Inc. at an exercise price of $4.16, vesting monthly over one year.

Summary

• Frederic Guerard, a director of CalciMedica, Inc., was granted stock options on March 28, 2024.
• The options give Guerard the right to buy 10,000 shares of CalciMedica common stock at an exercise price of $4.16 per share.
• The options vest in equal monthly installments over a one-year period, starting from the grant date.
• Following the transaction, Guerard directly owns 10,000 derivative securities.

Sentiment

Score: 6

Explanation: The document is a routine filing related to stock option grants, which is generally neutral. It indicates confidence in the company's future, but doesn't provide any groundbreaking information.

Positives

• The granting of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule encourages continued service and contribution to the company over the next year.

Industry Context

Stock options are a common form of compensation for directors and executives in publicly traded companies, aligning their interests with shareholders and incentivizing company growth.

Comparison to Industry Standards

• Stock option grants are a standard practice in the biotechnology industry for compensating directors and aligning their interests with shareholders.
• The vesting schedule of one year is relatively common, although some companies may use longer vesting periods.

Stakeholder Impact

• The granting of stock options may have a slightly dilutive effect on existing shareholders.
• The options incentivize the director to work towards increasing shareholder value.

Key Dates